Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | bradykinin receptor B2 | Starlite/ChEMBL | References |
Cavia porcellus | Bradykinin B2 receptor | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Schistosoma mansoni | peptide (allatostatin)-like receptor | Bradykinin B2 receptor | 372 aa | 337 aa | 25.5 % |
Onchocerca volvulus | Mitochondrial inner membrane protein homolog | Bradykinin B2 receptor | 372 aa | 339 aa | 23.9 % |
Loa Loa (eye worm) | hypothetical protein | Bradykinin B2 receptor | 372 aa | 311 aa | 23.5 % |
Echinococcus granulosus | neuropeptide receptor | Bradykinin B2 receptor | 372 aa | 338 aa | 24.0 % |
Schistosoma mansoni | adenoreceptor | Bradykinin B2 receptor | 372 aa | 361 aa | 21.1 % |
Onchocerca volvulus | Bradykinin B2 receptor | 372 aa | 323 aa | 20.7 % | |
Onchocerca volvulus | Bradykinin B2 receptor | 372 aa | 305 aa | 24.3 % | |
Schistosoma japonicum | ko:K04134 cholinergic receptor, invertebrate, putative | Bradykinin B2 receptor | 372 aa | 313 aa | 19.2 % |
Schistosoma mansoni | biogenic amine (octopamine/dopamine) receptor | Bradykinin B2 receptor | 372 aa | 326 aa | 22.7 % |
Schistosoma japonicum | ko:K04135 adrenergic receptor, alpha 1a, putative | Bradykinin B2 receptor | 372 aa | 335 aa | 22.7 % |
Schistosoma japonicum | Rhodopsin, putative | Bradykinin B2 receptor | 372 aa | 323 aa | 20.4 % |
Brugia malayi | putative neuropeptide receptor NPR1 | Bradykinin B2 receptor | 372 aa | 312 aa | 24.0 % |
Loa Loa (eye worm) | neuropeptide F receptor | Bradykinin B2 receptor | 372 aa | 355 aa | 21.4 % |
Echinococcus multilocularis | neuropeptide receptor | Bradykinin B2 receptor | 372 aa | 305 aa | 24.6 % |
Echinococcus granulosus | pyroglutamylated rfamide peptide receptor | bradykinin receptor B2 | 391 aa | 354 aa | 19.2 % |
Onchocerca volvulus | Bradykinin B2 receptor | 372 aa | 383 aa | 20.9 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | heat shock protein 90 | 0.0264 | 1 | 1 |
Trypanosoma brucei | heat shock protein, putative | 0.0264 | 1 | 1 |
Leishmania major | heat shock protein 83-1 | 0.0264 | 1 | 1 |
Plasmodium vivax | heat shock protein 86, putative | 0.0264 | 1 | 1 |
Trypanosoma brucei | heat shock protein, putative | 0.0264 | 1 | 1 |
Trichomonas vaginalis | heat shock protein, putative | 0.0162 | 0.345 | 0.345 |
Schistosoma mansoni | heat shock protein | 0.0264 | 1 | 1 |
Trichomonas vaginalis | heat shock protein, putative | 0.0211 | 0.655 | 0.655 |
Trypanosoma brucei | heat shock protein, putative | 0.0264 | 1 | 1 |
Trypanosoma cruzi | heat shock protein 90, putative | 0.0211 | 0.655 | 0.655 |
Trypanosoma brucei | heat shock protein, putative | 0.0264 | 1 | 1 |
Trypanosoma brucei | heat shock protein 90, putative | 0.0264 | 1 | 1 |
Leishmania major | heat shock protein 83-1 | 0.0264 | 1 | 1 |
Echinococcus granulosus | heat shock protein 90 | 0.0264 | 1 | 1 |
Leishmania major | heat shock protein 83-1 | 0.0264 | 1 | 1 |
Mycobacterium tuberculosis | Probable chaperone protein HtpG (heat shock protein) (HSP90 family protein) (high temperature protein G) | 0.0211 | 0.655 | 0.5 |
Trichomonas vaginalis | endoplasmin, putative | 0.0162 | 0.345 | 0.345 |
Leishmania major | heat shock protein 83-1 | 0.0264 | 1 | 1 |
Leishmania major | heat shock protein 83-1 | 0.0264 | 1 | 1 |
Wolbachia endosymbiont of Brugia malayi | heat shock protein 90 | 0.0211 | 0.655 | 0.5 |
Schistosoma mansoni | endoplasmin | 0.0264 | 1 | 1 |
Plasmodium falciparum | heat shock protein 90 | 0.0264 | 1 | 1 |
Leishmania major | heat shock protein 83-1 | 0.0264 | 1 | 1 |
Loa Loa (eye worm) | heat shock protein 90 | 0.0264 | 1 | 1 |
Plasmodium vivax | endoplasmin, putative | 0.0264 | 1 | 1 |
Trypanosoma cruzi | heat shock protein 85, putative | 0.0264 | 1 | 1 |
Trypanosoma cruzi | heat shock protein 90, putative | 0.0264 | 1 | 1 |
Trypanosoma cruzi | heat shock protein 90, putative | 0.0156 | 0.3058 | 0.3058 |
Giardia lamblia | Heat shock protein HSP 90-alpha | 0.0264 | 1 | 1 |
Leishmania major | heat shock protein 83-1 | 0.0264 | 1 | 1 |
Plasmodium falciparum | endoplasmin, putative | 0.0162 | 0.345 | 0.345 |
Echinococcus multilocularis | heat shock protein 90 | 0.0211 | 0.655 | 0.655 |
Trypanosoma cruzi | Heat shock protein 83, putative | 0.0264 | 1 | 1 |
Trypanosoma brucei | heat shock protein 90, putative | 0.0264 | 1 | 1 |
Leishmania major | heat shock protein 83-1 | 0.0264 | 1 | 1 |
Loa Loa (eye worm) | endoplasmin | 0.0264 | 1 | 1 |
Leishmania major | heat shock protein 83-1 | 0.0264 | 1 | 1 |
Trypanosoma brucei | heat shock protein, putative | 0.0264 | 1 | 1 |
Schistosoma mansoni | heat shock protein | 0.0264 | 1 | 1 |
Treponema pallidum | heat shock protein 90 | 0.0211 | 0.655 | 0.5 |
Mycobacterium leprae | PROBABLE CHAPERONE PROTEIN HTPG (HEAT SHOCK PROTEIN) (HSP90 FAMILY PROTEIN) (HIGH TEMPERATURE PROTEIN G) | 0.0211 | 0.655 | 0.5 |
Mycobacterium ulcerans | heat shock protein 90 | 0.0211 | 0.655 | 0.5 |
Leishmania major | heat shock protein 83-1 | 0.0264 | 1 | 1 |
Brugia malayi | heat shock protein 90 | 0.0264 | 1 | 1 |
Trypanosoma cruzi | heat shock protein 85, putative | 0.0211 | 0.655 | 0.655 |
Schistosoma mansoni | endoplasmin | 0.0264 | 1 | 1 |
Leishmania major | heat shock protein 83-1 | 0.0264 | 1 | 1 |
Leishmania major | heat shock protein 83-1 | 0.0264 | 1 | 1 |
Echinococcus granulosus | heat shock protein 90 | 0.0211 | 0.655 | 0.655 |
Trypanosoma brucei | heat shock protein, putative | 0.0264 | 1 | 1 |
Entamoeba histolytica | heat shock protein 90, putative | 0.0264 | 1 | 1 |
Leishmania major | heat shock protein 83-1 | 0.0264 | 1 | 1 |
Entamoeba histolytica | heat shock protein 90, putative | 0.0264 | 1 | 1 |
Trichomonas vaginalis | heat shock protein, putative | 0.0211 | 0.655 | 0.655 |
Echinococcus multilocularis | heat shock protein | 0.0264 | 1 | 1 |
Trypanosoma brucei | Heat shock protein 83, putative | 0.0264 | 1 | 1 |
Echinococcus granulosus | heat shock protein | 0.0264 | 1 | 1 |
Echinococcus granulosus | heat shock protein heat shock protein 90 alpha | 0.0211 | 0.655 | 0.655 |
Leishmania major | heat shock protein 83-1 | 0.0264 | 1 | 1 |
Toxoplasma gondii | heat shock protein 90, putative | 0.0264 | 1 | 1 |
Trypanosoma cruzi | heat shock protein 85, putative | 0.0264 | 1 | 1 |
Trichomonas vaginalis | heat shock protein, putative | 0.0264 | 1 | 1 |
Leishmania major | lipophosphoglycan biosynthetic protein, putative,heat shock protein 90, putative,glucose regulated protein 94, putative | 0.0211 | 0.655 | 0.655 |
Echinococcus multilocularis | endoplasmin | 0.0211 | 0.655 | 0.655 |
Leishmania major | heat shock protein 83-1 | 0.0264 | 1 | 1 |
Onchocerca volvulus | Heat shock protein 75 kDa, mitochondrial homolog | 0.0108 | 0 | 0.5 |
Trypanosoma cruzi | heat shock protein 85, putative | 0.0264 | 1 | 1 |
Trichomonas vaginalis | heat shock protein, putative | 0.0211 | 0.655 | 0.655 |
Leishmania major | heat shock protein 83-1 | 0.0264 | 1 | 1 |
Toxoplasma gondii | heat shock protein HSP90 | 0.0264 | 1 | 1 |
Trypanosoma brucei | heat shock protein, putative | 0.0264 | 1 | 1 |
Trypanosoma brucei | heat shock protein, putative | 0.0264 | 1 | 1 |
Leishmania major | heat shock protein 83-1 | 0.0264 | 1 | 1 |
Echinococcus granulosus | endoplasmin | 0.0211 | 0.655 | 0.655 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 0.68 nM | Concentration required to inhibit specific binding of [ 3H]BK (0.06 nM) to Bradykinin receptor B2 in guinea pig ileum membrane preparations by 50%. | ChEMBL. | 9767643 |
IC50 (binding) | = 4.6 nM | Inhibition specific binding of [3H]-BK (1.0 nM) to human Bradykinin receptor B2 which was expressed in CHO (Chinese hamster ovary) cells by 50%. | ChEMBL. | 9767643 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.